This article was updated with additional details from an Invitae-led study, which a breast surgeon group cited in recommending multigene panel hereditary cancer risk testing for all breast cancer patients.
NEW YORK (GenomeWeb) – Invitae will soon start allowing consumers to initiate test orders online, but the company isn't expecting this channel to immediately contribute to revenue growth in a big way.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
